Zobair M Younossi MD MPH is the Chairman of the Global NASH/MASH Council, Washington DC and Professor and Chairman of Beatty Liver and Obesity Research, Inova Health System, Falls Church, Virginia. Dr. Younossi earned his medical degree from University of Rochester (AOA 1989) with fellowship training in at Scripps Clinic and Research Foundation (1989-1995), while earning his Master of Public Health with multiple honours from San Diego State University (1995).
Wendy Lo is a patient advocate, speaker and consultant for liver health and hepatitis elimination. Her advocacy spans speaking appearances, consulting on patient engagement, community outreach, and activism for public health and policy changes. Visit wendylo.com for more information.
Dr. Evon is a clinical health psychologist, Professor of Medicine in the Division of GI and Hepatology at the University of North Carolina in Chapel Hill since 2005. She is a clinician and behavioral researcher in the field of chronic liver disease for 20 years. Clinically, she works with patients with MASLD/MASH to make lifestyle changes to improve liver health and achieve weight loss and with patients with cirrhosis and other liver diseases on coping, adjustment and self-management. Dr. Evon is also very passionate about patient-centered outcomes research.
Ravshan Yakubov, MBA, CPA, CA is an accounting and finance professional who lives in Ottawa, Canada. Born and raised in Uzbekistan, Ravshan lived, worked and studied in Europe, the USA and Canada.<br>Ravshan (Rav) was first infected with Hep B in his early childhood at the age of 2 during regular vaccination (via dirty needle). He was diagnosed with chronic Hep B infection at the age of 6.
Chari Cohen is President of the Hepatitis B Foundation. She conducts research and implements programs to reduce health disparities and improve health outcomes associated with hepatitis B, hepatitis D and liver cancer. Dr. Cohen is co-chair of the Hep B United coalition, co-founder and chair of Hep B United Philadelphia, co-founder and chair of CHIPO: Coalition Against Hepatitis for People of African Origin.
Dr. Carolyn Wester serves as the Director of the Division of Viral Hepatitis within CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention. She has over 25 years of public health and clinical research experience focused on the prevention, diagnosis, and treatment of viral hepatitis, HIV, and STIs in the U.S. and internationally. In her current role, Dr.
Alina M. Allen, M.D.,M.S. is Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. <br>She is a physician scientist with an NIH-funded research program focused on improving outcomes in patients with metabolic dysfunction associated steatotic liver disease (MASLD).
Veronica Miller PhD, Adjunct Professor at Berkeley Public Health, directs the Forum for Collaborative Research and its Data & Analysis Center. The Forum applies innovative translational medicine approaches to complex high-prevalence and rare diseases (steatotic/ cholestatic liver diseases, viral infections, ocular diseases) requiring multi-modal approaches to generate solutions. This involves multidisciplinary teams in Public Health, Medicine, Biology, Statistics, Computer Science, Data/Regulatory Science from academia, industry, governments and communities.